Clinical Trial Results:
A multicentre, double-blind, randomised, parallel-group study to evaluate the efficacy, safety and tolerability of ezetimibe/simvastatin 10/40mg, atorvastatin 40mg, and rosuvastatin 10mg to achieve an LDL-C level of <2mmol/l in patients with established CVD or at “high risk” of developing CVD, currently treated with simvastatin 40mg and with a fasting LDL-C 2 mmol/l
Summary
|
|
EudraCT number |
2006-006219-56 |
Trial protocol |
GB |
Global completion date |
26 Jun 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Aug 2019
|
First version publication date |
28 Aug 2019
|
Other versions |
|
Summary report(s) |
EudraCT Summary Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.